Philip Morris Allowed to Say IQOS Reduces Harmful Exposure
- FDA stops short of letting device be marketed as reduced risk
- Decision concludes nearly review period of nearly four years
This article is for subscribers only.
Philip Morris International Inc. can market its IQOS products as reducing consumers’ exposure to harmful chemicals found in cigarettes, the U.S. Food and Drug Administration said Tuesday.
IQOS heats tobacco rather than burning it, a process seen as less harmful than smoking conventional cigarettes. The FDA last year allowed IQOS, which is an electronic device that uses a tobacco plug, to be sold in the U.S. while it reviewed Philip Morris’s modified-risk product application.